# Podoconiosis-Disability-and-Depression-Study
This repository contains some research work done on the effects of lymphoedema management disability and depression related to non-filarial elephantiasis (podoconiosis)
# Podoconiosis Morbidity Management: Effects on Disability and Depression

[![Study Status](https://img.shields.io/badge/Study-Completed-success)](https://github.com)
[![License](https://img.shields.io/badge/License-CC%20BY%204.0-lightgrey.svg)](https://creativecommons.org/licenses/by/4.0/)
[![Data](https://img.shields.io/badge/Data-Available%20on%20Request-blue)](mailto:swanji@yahoo.fr)

> **A 24-month prospective study evaluating morbidity management outcomes in podoconiosis patients in Cameroon**

> âš ï¸ **Note:** Full manuscript is in preparation for submission to a peer-reviewed journal. This repository provides research materials, code, and summary findings to support transparency and reproducibility.

---

## ğŸ“‹ Table of Contents
- [Overview](#-overview)
- [Research Significance](#-research-significance)
- [Study Design](#-study-design)
- [Data & Code Availability](#-data--code-availability)
- [Key Methodological Contributions](#-key-methodological-contributions)
- [Preliminary Findings](#-preliminary-findings)
- [Repository Structure](#-repository-structure)
- [How to Use This Repository](#-how-to-use-this-repository)
- [Ethics & Data Sharing](#-ethics--data-sharing)
- [Citation](#-citation)
- [Contact](#-contact)

---

## ğŸ¯ Overview

### Research Question
Can simple lymphoedema management (foot hygiene, elevation, footwear) significantly reduce disability and depressive symptoms in podoconiosis patients over 24 months?

### Context
- **Disease:** Podoconiosis (non-filarial elephantiasis from volcanic soil exposure)
- **Location:** North West Region, Cameroon
- **Population:** 199 patients enrolled, 161 completed full follow-up (81% retention)
- **Duration:** March 2019 - March 2022
- **Study Type:** Prospective interventional study with repeated measures

### What Makes This Study Novel

| Feature | Innovation |
|---------|-----------|
| **Dual outcome assessment** | First study to simultaneously evaluate disability (WHODAS 2.0) AND depression (PHQ-9) |
| **Extended follow-up** | Longest prospective study in Cameroon (24 months vs. previous cross-sectional studies) |
| **Compliance analysis** | Quantified adherence effects using validated hygiene assessment tool |
| **Economic impact** | First national productivity calculation for podoconiosis treatment in Africa |
| **Detailed domain analysis** | Used IRT scoring for granular disability subscale assessment |

---

## ğŸ”¬ Research Significance

### The Problem Addressed

**Podoconiosis in Cameroon:**
- ~41,556 estimated cases nationwide
- Prevalence up to 8.1% in endemic highland areas
- Only 1 treatment center for entire country
- Limited evidence on treatment effectiveness

**Patient Burden:**
- 65% experience depression at baseline
- Average 2.6 days/month unable to work
- 46% have acute inflammatory attacks monthly
- Profound social stigma and isolation

### Knowledge Gaps Filled

**Before this study:**
- âŒ No long-term disability data from Cameroon
- âŒ No evidence linking treatment to mental health improvement
- âŒ Unknown economic benefits of intervention
- âŒ Unclear if compliance level affects outcomes

**After this study:**
- âœ… 24-month longitudinal disability data
- âœ… Validated mental health outcome measurements
- âœ… Quantified productivity gains and national impact
- âœ… Differential effects of compliance on physical vs. mental health

---

## ğŸ”¬ Study Design

### Design Overview

```
PROSPECTIVE SINGLE-ARM INTERVENTIONAL STUDY

Enrollment (N=199)
    â†“
Baseline Assessment (T0)
    â”œâ”€â”€ WHODAS 2.0 (disability)
    â”œâ”€â”€ PHQ-9 (depression)
    â”œâ”€â”€ Workdays lost
    â”œâ”€â”€ Sociodemographics
    â””â”€â”€ Clinical staging
    â†“
Intervention: Morbidity Management
    â”œâ”€â”€ Foot hygiene education
    â”œâ”€â”€ Supplies provided (soap, Vaseline, etc.)
    â”œâ”€â”€ Visit schedule: 2, 4, 6, 12, 18, 24 months
    â””â”€â”€ ADLA management as needed
    â†“
12-Month Assessment (T1) [N=177, 88.9%]
    â”œâ”€â”€ WHODAS 2.0
    â”œâ”€â”€ PHQ-9
    â”œâ”€â”€ Hygiene compliance
    â””â”€â”€ Clinical evaluation
    â†“
24-Month Assessment (T2) [N=161, 80.9%]
    â”œâ”€â”€ WHODAS 2.0
    â”œâ”€â”€ PHQ-9
    â”œâ”€â”€ Hygiene compliance
    â””â”€â”€ Clinical evaluation
    â†“
Analysis (N=161 completers)
    â”œâ”€â”€ Within-subject changes
    â”œâ”€â”€ Compliance effects (mixed models)
    â””â”€â”€ Economic extrapolation
```

### Participants

**Inclusion Criteria:**
- Stage 2-3 podoconiosis (Tekola scale)
- Age 18-65 years
- Negative for lymphatic filariasis (ICT)
- Resident in North West Region â‰¥2 years

**Exclusion Criteria:**
- Lymphoedema from other causes
- Pregnancy
- Body weight <40 kg
- Cognitive impairment affecting consent

### Intervention Protocol

**Daily Self-Care (taught at baseline, reinforced at visits):**

1. **Foot hygiene:**
   - Soak affected limb(s) in antiseptic water (15-20 min)
   - Wash with mild soap (pH <9)
   - Scrub skin folds and under toenails
   - Rinse and dry thoroughly
   - Apply petroleum jelly

2. **Foot care:**
   - Elevate legs when sitting/sleeping
   - Perform foot/calf exercises (except during acute attacks)
   - Wear closed shoes during all waking hours
   - Bandage if wounds present

3. **Supplies provided:**
   - Soap, petroleum jelly, antiseptics
   - Towels, buckets, socks (as needed)
   - Gauze and bandages for wound care

### Outcome Measures

| Instrument | Domain | Scoring | Administration |
|------------|--------|---------|----------------|
| **WHODAS 2.0 (12-item)** | Disability across 6 domains | 0-100 (higher=worse) | Interviewer-administered |
| **PHQ-9** | Depression severity | 0-27 (â‰¥5=depression) | Interviewer-administered |
| **Workdays Lost** | Economic productivity | Days totally unable to work (past 30 days) | Self-report |
| **Hygiene Assessment** | Compliance | 0-30 (â‰¥24.5=good) | Mixed (self-report + observer) |

**WHODAS 2.0 Domains:**
1. Cognition (understanding, concentrating)
2. Mobility (standing, walking)
3. Self-care (washing, dressing)
4. Getting along (interpersonal relationships)
5. Life activities (household, work responsibilities)
6. Participation (community engagement)

**Scoring Methods:**
- Simple scoring: Summation converted to 0-100 metric
- IRT scoring: Differential weighting for domain analysis
- Subscales: Activity Limitation + Participation Restriction

---

## ğŸ“Š Data & Code Availability

### Data Access

**Deidentified dataset available upon request to:**
- Prof. Samuel Wanji: swanji@yahoo.fr
- Requirements:
  - Institutional ethics approval
  - Data use agreement
  - Research proposal outlining intended use

**Dataset includes:**
- Sociodemographic variables
- WHODAS 2.0 and PHQ-9 scores (all timepoints)
- Hygiene assessment scores
- Clinical staging data
- ADLA episode frequency
- Workdays lost records

**Restrictions:**
- No redistribution to third parties
- Non-commercial research use only
- Must cite original publication

### Code Repository

All analysis code is available in this repository:

```
/code
â”œâ”€â”€ /data_cleaning
â”‚   â”œâ”€â”€ 01_redcap_export.R
â”‚   â”œâ”€â”€ 02_variable_recoding.R
â”‚   â””â”€â”€ 03_compliance_scoring.R
â”œâ”€â”€ /descriptive_stats
â”‚   â”œâ”€â”€ 04_baseline_characteristics.R
â”‚   â”œâ”€â”€ 05_attrition_analysis.R
â”‚   â””â”€â”€ 06_domain_distributions.R
â”œâ”€â”€ /primary_analysis
â”‚   â”œâ”€â”€ 07_wilcoxon_signed_rank.R
â”‚   â”œâ”€â”€ 08_disability_changes.R
â”‚   â””â”€â”€ 09_depression_changes.R
â”œâ”€â”€ /secondary_analysis
â”‚   â”œâ”€â”€ 10_mixed_effects_models.R
â”‚   â”œâ”€â”€ 11_compliance_analysis.R
â”‚   â””â”€â”€ 12_sociodemographic_associations.R
â”œâ”€â”€ /visualizations
â”‚   â”œâ”€â”€ 13_boxplots_stripcharts.R
â”‚   â”œâ”€â”€ 14_domain_heatmaps.R
â”‚   â””â”€â”€ 15_trend_plots.R
â””â”€â”€ /economic_impact
    â”œâ”€â”€ 16_workdays_analysis.R
    â””â”€â”€ 17_national_extrapolation.R
```

**Software Used:**
- R version 4.0.5 (primary analysis)
- IBM SPSS Statistics 25 (mixed models)
- Microsoft Excel 2010 (data management)
- REDCap 7.0.6 (data capture)

### Instruments

All questionnaires are available in `/instruments`:

```
/instruments
â”œâ”€â”€ WHODAS_2.0_12item_interviewer.pdf
â”œâ”€â”€ PHQ9_questionnaire.pdf
â”œâ”€â”€ Hygiene_Assessment_Form.pdf
â”œâ”€â”€ Sociodemographic_Form.pdf
â””â”€â”€ Informed_Consent_English_Pidgin.pdf
```

---

## ğŸ”§ Key Methodological Contributions

### 1. Dual Scoring Approach for WHODAS 2.0

**Innovation:** Combined simple and IRT-based scoring methods

```R
# Simple scoring (overall disability)
simple_score <- (sum(items_1_to_12) / 48) * 100

# IRT scoring (domain-specific analysis)
domain_scores <- list(
  cognition = (S3 + S6) / 8 * 100,
  mobility = (S1 + S7) / 8 * 100,
  self_care = (S8 + S9) / 6 * 100,
  getting_along = (S10 + S11) / 4 * 100,
  life_activities = (S2 + S12) / 6 * 100,
  participation = (S4 + S5) / 6 * 100
)

# Subscale aggregation
activity_limitation <- (S1 + S3 + S6 + S7 + S8 + S9) / 22 * 100
participation_restriction <- (S2 + S4 + S5 + S10 + S11 + S12) / 16 * 100
```

**Why this matters:**
- Simple scoring: Tracks overall change for clinical decisions
- IRT scoring: Identifies which life domains improve most
- Subscales: Differentiates physical vs. social disability

### 2. Compliance Quantification

**Innovation:** Objective scoring system combining self-report and observation

**Hygiene Assessment Scoring:**

| Component | Points | Assessment Method |
|-----------|--------|-------------------|
| Washing frequency | 0-3 | Self-report |
| Soap use | 0-1 | Self-report + observation |
| Elevation practice | 0-3 | Self-report |
| Footwear use | 0-2 | Observation |
| Skin cleanliness | 0-6 | Independent observer |
| Nail care | 0-3 | Independent observer |
| Wound status | 0-3 | Independent observer |
| Facility availability | 0-9 | Observation |
| **Total** | **0-30** | **Mixed** |

**Compliance Classification:**
- Good compliance: Mean score â‰¥24.5 across visits
- Poor compliance: Mean score <24.5
- Cut-off based on sample mean (data-driven threshold)

### 3. Mixed-Effects Modeling for Compliance

**Model Specification:**

```R
# Disability model
lmer(WHODAS_score ~ 
       time * compliance_status +  # Interaction term
       age + sex + education + marital_status +  # Covariates
       (1 | participant_id),  # Random intercept
     data = long_data,
     REML = TRUE)

# Depression model (same structure)
lmer(PHQ9_score ~ 
       time * compliance_status + 
       age + education +  # Reduced covariates (sex not sig)
       (1 | participant_id),
     data = long_data,
     REML = TRUE)
```

**Why mixed models:**
- Accounts for repeated measures within individuals
- Handles missing data (not just completers)
- Tests time Ã— compliance interaction
- Estimates marginal means at each timepoint

### 4. Economic Impact Extrapolation

**Calculation Method:**

```R
# Individual level
workdays_gained_per_month <- mean(baseline_days) - mean(endpoint_days)
# = 2.6 - 1.3 = 1.3 days/month

# Study cohort (24 months)
total_days_gained <- 161 * 1.3 * 24
# = 5,023 person-days

# National extrapolation
national_cases <- 41556  # From Deribe et al. 2018
national_days_gained <- national_cases * 1.3 * 24 / 12  # Per year
# = 1,296,768 person-days/year

# Convert to person-years
person_years_gained <- national_days_gained / 365
# = 3,553 person-years over 24 months
```

**Assumptions:**
1. Treatment effects generalise to all Cameroon cases
2. Adherence rates in scaled programs similar to the trial
3. Baseline disability comparable across regions
4. Linear extrapolation (conservative estimate)

---

## ğŸ“ˆ Preliminary Findings

> âš ï¸ **Note:** Detailed results are reserved for peer-reviewed publication. Summary statistics provided here for methodological transparency and portfolio purposes.

### Sample Characteristics (N=161 completers)

| Characteristic | n (%) or MeanÂ±SD |
|----------------|------------------|
| Age (years) | 42.5 Â± 11.8 |
| Female sex | 146 (90.7%) |
| Education (years) | 9.6 Â± 6.1 |
| Married/partnered | 84 (52.2%) |
| Farmers/self-employed | 125 (77.6%) |
| Both legs affected (stage 2-3) | 108 (67.1%) |

### Primary Outcomes: Direction of Change

**Disability (WHODAS 2.0):**
- Baseline â†’ 12 months: Significant decrease (p<0.001)
- Baseline â†’ 24 months: Significant decrease (p<0.001)
- 12 months â†’ 24 months: Modest increase (p<0.05)
- **Pattern:** Large initial improvement, sustained benefits with slight attenuation

**Depression (PHQ-9):**
- Baseline â†’ 12 months: Significant decrease (p<0.001)
- Baseline â†’ 24 months: Significant decrease (p<0.001)
- 12 months â†’ 24 months: Small increase (not significant)
- **Pattern:** Substantial improvement maintained over 24 months

**Workdays Lost:**
- Baseline â†’ 24 months: Significant decrease (p<0.001)
- Mean change: 1.3 days/month gained
- **Pattern:** Economic productivity substantially recovered

### Domain-Specific Findings

All six WHODAS 2.0 domains showed significant improvement (p<0.001 for all):

| Domain | Direction | Relative Magnitude |
|--------|-----------|-------------------|
| Cognition | â†“â†“â†“ | Large effect |
| Mobility | â†“â†“ | Moderate effect |
| Self-care | â†“â†“â†“ | Large effect |
| Getting along | â†“â†“â†“ | Large effect |
| Life activities | â†“â†“ | Moderate effect |
| Participation | â†“â†“â†“ | Very large effect |

**Key observation:** Social/participation domains improved more dramatically than physical domains (mobility, self-care)â€”suggests intervention addresses stigma and isolation, not just physical symptoms.

### Compliance Effects

**Finding:** Differential impact on outcomes

| Outcome | Compliance Effect | Interpretation |
|---------|-------------------|----------------|
| Disability | No significant difference (p=0.408) | Physical benefits occur regardless of adherence level |
| Depression | Significant difference (p=0.008) | Mental health requires consistent engagement |

**Clinical implication:** Even imperfect adherence provides valueâ€”programs should prioritise access over perfect compliance.

### Sociodemographic Patterns

**Baseline associations attenuated post-intervention:**
- Age â‰¥45 years: Higher depression at baseline â†’ No difference at 24 months
- Farmers: Higher depression at baseline â†’ No difference at 24 months
- **Interpretation:** Intervention may reduce health inequities

---

## ğŸ“ Repository Structure

```
podoconiosis-disability-study/
â”œâ”€â”€ README.md                          # This file
â”œâ”€â”€ LICENSE                            # CC BY 4.0
â”œâ”€â”€ /code                              # Analysis scripts
â”‚   â”œâ”€â”€ /data_cleaning
â”‚   â”œâ”€â”€ /descriptive_stats
â”‚   â”œâ”€â”€ /primary_analysis
â”‚   â”œâ”€â”€ /secondary_analysis
â”‚   â”œâ”€â”€ /visualizations
â”‚   â””â”€â”€ /economic_impact
â”œâ”€â”€ /instruments                       # Questionnaires (English/Pidgin)
â”‚   â”œâ”€â”€ WHODAS_2.0_12item.pdf
â”‚   â”œâ”€â”€ PHQ9.pdf
â”‚   â”œâ”€â”€ Hygiene_Assessment_Form.pdf
â”‚   â””â”€â”€ Informed_Consent.pdf
â”œâ”€â”€ /documentation                     # Study protocols & forms
â”‚   â”œâ”€â”€ Study_Protocol_Summary.pdf
â”‚   â”œâ”€â”€ Ethics_Approval_CNERSH.pdf
â”‚   â”œâ”€â”€ Participant_Information_Sheet.pdf
â”‚   â””â”€â”€ Data_Management_Plan.pdf
â”œâ”€â”€ /results                           # Summary outputs (not full manuscript)
â”‚   â”œâ”€â”€ /tables
â”‚   â”‚   â”œâ”€â”€ Table_1_Baseline_Characteristics.csv
â”‚   â”‚   â”œâ”€â”€ Table_2_Primary_Outcomes.csv
â”‚   â”‚   â””â”€â”€ Table_3_Domain_Analysis.csv
â”‚   â”œâ”€â”€ /figures
â”‚   â”‚   â”œâ”€â”€ Fig_1_Study_Flow_Diagram.png
â”‚   â”‚   â”œâ”€â”€ Fig_2_Disability_Trends.png
â”‚   â”‚   â”œâ”€â”€ Fig_3_Depression_Trends.png
â”‚   â”‚   â””â”€â”€ Fig_4_Compliance_Effects.png
â”‚   â””â”€â”€ /supplementary
â”‚       â”œâ”€â”€ Supp_Table_1_Attrition_Analysis.csv
â”‚       â””â”€â”€ Supp_Fig_1_Domain_Heatmap.png
â””â”€â”€ /data                              # Placeholder (actual data on request)
    â”œâ”€â”€ README_data_request.md
    â””â”€â”€ data_dictionary.csv
```

---

## ğŸš€ How to Use This Repository

### For Researchers Interested in Methods

```bash
# Clone repository
git clone https://github.com/yourusername/podoconiosis-disability-study.git

# Navigate to code
cd code/primary_analysis

# Run example analysis (requires R 4.0+)
Rscript 08_disability_changes.R
```

**Dependencies:**
```R
# Install required packages
install.packages(c("lme4", "ggplot2", "dplyr", "tidyr", 
                   "psych", "coin", "effectsize"))
```

### For Clinicians Planning Similar Interventions

**Key resources:**
1. `/instruments` â†’ Use same validated tools for comparability
2. `/documentation/Study_Protocol_Summary.pdf` â†’ Adapt intervention protocol
3. `/code/descriptive_stats` â†’ Calculate sample size for your setting

### For Students Learning Epidemiology/Biostatistics

**Educational use cases:**
1. **Mixed-effects modeling:** See `/code/secondary_analysis/10_mixed_effects_models.R`
2. **Longitudinal data visualization:** See `/code/visualizations/15_trend_plots.R`
3. **Non-parametric tests:** See `/code/primary_analysis/07_wilcoxon_signed_rank.R`
4. **Economic impact analysis:** See `/code/economic_impact/17_national_extrapolation.R`

### For Data Requesters

**To access deidentified dataset:**

1. Email Prof. Samuel Wanji (swanji@yahoo.fr) with:
   - Brief research proposal (1-2 pages)
   - Proof of institutional ethics approval
   - Intended use and analysis plan
   - Data sharing agreement acknowledgment

2. Review `/data/data_dictionary.csv` for variable definitions

3. Use provided code as starting point for analysis

---

## ğŸ”’ Ethics & Data Sharing

### Ethics Approval

- **Committee:** National Ethics Committee for Health Research on Humans (CNERSH), Cameroon
- **Approval Number:** [Available upon publication]
- **Date:** March 2019
- **Trial Registration:** Part of TAKeOFF-PodoLEDoxy trial (BMBF-funded)

### Informed Consent

- Written informed consent obtained from all participants
- Information provided in English or Pidgin English
- Voluntary participation with right to withdraw anytime
- No penalties for withdrawal

### Data Protection

**Confidentiality measures:**
- Participants identified by unique codes (no names)
- Personal identifiers removed from shared datasets
- Data stored on encrypted, password-protected servers
- Access restricted to authorized research team members

**Data retention:**
- Raw data retained for 10 years post-publication (University of Buea repository)
- Deidentified data available indefinitely for research purposes

### Ethical Data Sharing

**We share data to:**
- âœ… Support reproducibility and verification
- âœ… Enable meta-analyses and secondary research
- âœ… Maximize research value and societal benefit
- âœ… Meet funder requirements (BMBF)

**We protect participants by:**
- âŒ No personally identifiable information shared
- âŒ No data redistribution without permission
- âŒ No commercial use of data
- âœ… Requiring ethics approval from requesters

---

## ğŸ“š Background Literature

### Podoconiosis Epidemiology

1. **Deribe K, et al.** (2018). Predicted distribution and burden of podoconiosis in Cameroon. *BMJ Glob Health* 3(3):e000730. [doi:10.1136/bmjgh-2018-000730](https://doi.org/10.1136/bmjgh-2018-000730)

2. **Wanji S, et al.** (2018). Study of lymphoedema of non-filarial origin in the northwest region of Cameroon. *Int Health* 10(4):285-293. [doi:10.1093/inthealth/ihy029](https://doi.org/10.1093/inthealth/ihy029)

3. **Deribe K, et al.** (2018). Global epidemiology of podoconiosis: A systematic review. *PLoS Negl Trop Dis* 12(3):e0006324. [doi:10.1371/journal.pntd.0006324](https://doi.org/10.1371/journal.pntd.0006324)

### Mental Health in Podoconiosis

4. **Semrau M, et al.** (2019). Depressive symptoms amongst people with podoconiosis and lower limb lymphoedema of other cause in Cameroon: A cross-sectional study. *Trop Med Infect Dis* 4(3):102. [doi:10.3390/tropicalmed4030102](https://doi.org/10.3390/tropicalmed4030102)

5. **Bartlett J, et al.** (2016). Depression and disability in people with podoconiosis: A comparative cross-sectional study. *Int Health* 8(2):124-131. [doi:10.1093/inthealth/ihv037](https://doi.org/10.1093/inthealth/ihv037)

### Treatment Effectiveness

6. **Budge PJ, et al.** (2013). Impact of community-based lymphoedema management on perceived disability in lymphatic filariasis. *PLoS Negl Trop Dis* 7(3):e2100. [doi:10.1371/journal.pntd.0002100](https://doi.org/10.1371/journal.pntd.0002100)

7. **Negussie H, et al.** (2018). Lymphoedema management to prevent acute dermatolymphangioadenitis in podoconiosis (GoLBeT): A pragmatic RCT. *Lancet Glob Health* 6(7):e795-e803. [doi:10.1016/S2214-109X(18)30124-4](https://doi.org/10.1016/S2214-109X(18)30124-4)

### Measurement Instruments

8. **ÃœstÃ¼n TB, et al.** (2010). *Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0)*. WHO, Geneva.

9. **Kroenke K, et al.** (2001). The PHQ-9: Validity of a brief depression severity measure. *J Gen Intern Med* 16(9):606-613. [doi:10.1046/j.1525-1497.2001.016009606.x](https://doi.org/10.1046/j.1525-1497.2001.016009606.x)

---

## ğŸ“ Citation

### Repository Citation

**Until manuscript is published, cite this repository as:**

```bibtex
@misc{ndeugue2024podoconiosis_repo,
  author = {Ndeugue Nouyou, Michel and Eyong, Esum Mathias and 
            Njouendou, Abdel Jelil and Wanji, Samuel},
  title = {Podoconiosis Morbidity Management: Effects on Disability and 
           Depression - Research Materials and Code},
  year = {2024},
  publisher = {GitHub},
  howpublished = {\url{https://github.com/yourusername/podoconiosis-disability-study}},
  note = {Research materials for manuscript in preparation}
}
```

### Thesis Citation

**Original research documented in:**

```bibtex
@mastersthesis{ndeugue2022thesis,
  author = {Ndeugue Nouyou, Michel},
  title = {Effects of Morbidity Management on Disability and Depressive Symptoms 
           of Podoconiosis Patients, 12 and 24 Months Following Intervention in 
           the North West Region of Cameroon},
  school = {University of Buea, Faculty of Science, Department of Microbiology 
            and Parasitology},
  year = {2022},
  type = {MSc thesis in Epidemiology and Control of Infectious Diseases},
  address = {Buea, Cameroon}
}
```

### Manuscript Citation (Upon Publication)

**When published, please cite the peer-reviewed article instead of this repository. Repository will be updated with publication DOI.**

---

## ğŸ”¬ Study Team

### Principal Investigator
**Prof. Samuel Wanji, PhD**  
Department of Microbiology and Parasitology, University of Buea  
ğŸ“§ swanji@yahoo.fr

### Lead Analyst & Author
**Michel Ndeugue Nouyou, MSc**  
MSc in Epidemiology and Control of Infectious Diseases  
BSc in Clinical Biochemistry  
ğŸ“§ ndeuguemic@gmail.com

### Academic Supervisors
**Dr. Esum Mathias Eyong**  
Senior Lecturer, Department of Microbiology and Parasitology, University of Buea

**Dr. Njouendou Abdel Jelil**  
Lecturer, Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea

### Collaborators
TAKeOFF Project Team, Bamenda Clinical Trial Centre:
- Mr. Ebua Gallus
- Dr. Nji Theobald
- Mr. Nkwetta Derick
- Mrs. Tamiya Sandrine
- Mr. Bonekeh John
- Mr. Nchanji Takop
- Mr. Ndzshang Bertrand
- Miss Bangsi Rose

---

## ğŸ¤ Funding & Acknowledgments

### Funding Source
**Federal Ministry of Education and Research (BMBF), Germany**  
TAKeOFF-PodoLEDoxy Trial

### Acknowledgments
- All study participants for their time and commitment
- Community health workers who recruited participants
- Traditional leaders and health authorities in the North West Region
- Bamenda Clinical Trial Centre staff
- University of Buea for institutional support

### Conflicts of Interest
None declared.

---

## ğŸ“§ Contact & Collaboration

### For Scientific Inquiries
ğŸ“§ **Michel Ndeugue Nouyou:** ndeuguemic@gmail.com  
ğŸ’¼ **LinkedIn:** [Link to profile]  
ğŸ“ **ResearchGate:** [Link to profile]

### For Data Requests
ğŸ“§ **Prof. Samuel Wanji:** swanji@yahoo.fr  
ğŸ›ï¸ **Institution:** University of Buea, Cameroon

### For Clinical/Implementation Questions
ğŸ¥ **Bamenda Clinical Trial Centre**  
ğŸ“ Foncha Street, Nkwen, Bamenda III, North West Region, Cameroon

### For Collaboration Opportunities

**We welcome collaborations on:**
- Meta-analyses of NTD morbidity management interventions
- Multi-country comparative effectiveness studies
- Implementation science research on scaling podoconiosis programs
- Mental health interventions in NTD populations
- Economic evaluations and cost-effectiveness analyses
- Stigma reduction strategies

**Please email with:**
- Brief description of proposed collaboration
- Your institution and role
- Timeline and resource considerations

---

## ğŸ“œ License

### Code License
All analysis code in this repository is licensed under the **MIT License**.

```
MIT License

Copyright (c) 2024 Michel Ndeugue Nouyou

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT.
```

### Documentation & Data License
All documentation and data (when shared) are licensed under **Creative Commons Attribution 4.0 International (CC BY 4.0)**.

[![License: CC BY 4.0](https://licensebuttons.net/l/by/4.0/88x31.png)](https://creativecommons.org/licenses/by/4.0/)

**You are free to:**
- **Share** â€” copy and redistribute the material
- **Adapt** â€” remix, transform, and build upon the material

**Under the following terms:**
- **Attribution** â€” You must give appropriate credit, provide a link to the license, and indicate if changes were made

---

## âš ï¸ Disclaimer

This repository contains research materials and code for transparency and reproducibility purposes. **Detailed results, interpretation, and clinical recommendations are reserved for the forthcoming peer-reviewed publication.**

Summary statistics and methodological information provided here are:
- âœ… Sufficient for understanding study design
- âœ… Adequate for assessing methodological rigor
- âœ… Appropriate for replication in similar settings
- âŒ Not sufficient for systematic reviews or meta-analyses (await publication)
- âŒ Not intended as clinical practice guidelines (await publication)

**Clinical decisions should not be based solely on information in this repository.**

---

## ğŸ”„ Repository Updates

### Version History

| Version | Date | Changes |
|---------|------|---------|
| v0.1.0 | [Date] | Initial public
